Description
SWOT ANALYSIS OF ALLERGAN
Allergan
Parent Company
Allergan
Category
Pharmaceutical
Sector
Healthcare
Tagline/ Slogan
Our pursuit , Life’s potential
USP
It is world’s leading Botox manufacturer.
STP
Segment
Dermatology, ophthalmology, aesthetics & neurological disorders
Target Group
Healthcare professionals offering solutions in these areas
Allergan is unique combination of biotechnology, pharmaceutical & medical device manufacturing which avoids bureaucracy in favor of fast Positioning & efficient decision-making.
SWOT Analysis
1. It is market leader in Botox manufacturing 2. It has more than 10000 well trained employees 3. They have strong product pipeline 4. Their acquisition of Inamed has given them considerable presence in Strength aesthetics market
1. Majority of revenue comes from US based operations Weakness 2. Limited presence in emerging markets
1. Britain has approved use of Botox in migraine treatment which has opened up new market 2. There is consistent increase in world obese population 3. Increasing US ageing population with more prevalence of Opportunity neurological disorders
1. Expiration of major patents Threats 2. Global economic slowdown
3. Proposal to tax vanity procedure which is also called as ‘Botax’
Competition
1. Amgen Inc. 2. Genentech Inc. 3. Biogen Idec. Competitors 4. Genzyme
doc_154921281.docx
SWOT ANALYSIS OF ALLERGAN
Allergan
Parent Company
Allergan
Category
Pharmaceutical
Sector
Healthcare
Tagline/ Slogan
Our pursuit , Life’s potential
USP
It is world’s leading Botox manufacturer.
STP
Segment
Dermatology, ophthalmology, aesthetics & neurological disorders
Target Group
Healthcare professionals offering solutions in these areas
Allergan is unique combination of biotechnology, pharmaceutical & medical device manufacturing which avoids bureaucracy in favor of fast Positioning & efficient decision-making.
SWOT Analysis
1. It is market leader in Botox manufacturing 2. It has more than 10000 well trained employees 3. They have strong product pipeline 4. Their acquisition of Inamed has given them considerable presence in Strength aesthetics market
1. Majority of revenue comes from US based operations Weakness 2. Limited presence in emerging markets
1. Britain has approved use of Botox in migraine treatment which has opened up new market 2. There is consistent increase in world obese population 3. Increasing US ageing population with more prevalence of Opportunity neurological disorders
1. Expiration of major patents Threats 2. Global economic slowdown
3. Proposal to tax vanity procedure which is also called as ‘Botax’
Competition
1. Amgen Inc. 2. Genentech Inc. 3. Biogen Idec. Competitors 4. Genzyme
doc_154921281.docx